Jeremy D. Findlay
Eli Lilly (United Kingdom) · 17 works · 415 citations · h-index 12
Top works
- Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake
- ω-Agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, γ-aminobutyric acid and glutamate from rat brain slices
- 1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors
- Discovery and structure–activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors
- Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake
- Effect of Voltage‐Sensitive Calcium Channel Antagonists on the Release of 5‐Hydroxytryptamine from Rat Hippocampus In Vivo
- Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter
- N-Alkyl-N-arylmethylpiperidin-4-amines: Novel dual inhibitors of serotonin and norepinephrine reuptake
- SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis
- Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives
- Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR
- An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors
- A high-throughput model for investigating neuronal function and synaptic transmission in cultured neuronal networks
- Naphthyl piperazines with dual activity as 5-HT1D antagonists and 5-HT reuptake inhibitors
- Duloxetine (Cymbalta), a Dual Inhibitor of Serotonin and Norepinephrine Reuptake.
- CCDC 291659: Experimental Crystal Structure Determination
- 1‐Aryl‐3,4‐dihydro‐1H‐quinolin‐2‐one Derivatives, Novel and Selective Norepinephrine Reuptake Inhibitors.